245 related articles for article (PubMed ID: 32839414)
21. Flavonoid morin inhibits proliferation and induces apoptosis of melanoma cells by regulating reactive oxygen species, Sp1 and Mcl-1.
Lee YJ; Kim WI; Kim SY; Cho SW; Nam HS; Lee SH; Cho MK
Arch Pharm Res; 2019 Jun; 42(6):531-542. PubMed ID: 31049822
[TBL] [Abstract][Full Text] [Related]
22. Phytochemicals for the Management of Melanoma.
Pal HC; Hunt KM; Diamond A; Elmets CA; Afaq F
Mini Rev Med Chem; 2016; 16(12):953-79. PubMed ID: 26864554
[TBL] [Abstract][Full Text] [Related]
23. A dermatan sulfate-functionalized biomimetic nanocarrier for melanoma targeted chemotherapy.
Li S; Zhang F; Yu Y; Zhang Q
Carbohydr Polym; 2020 May; 235():115983. PubMed ID: 32122513
[TBL] [Abstract][Full Text] [Related]
24. Cannabinoids as a Potential New and Novel Treatment for Melanoma: A Pilot Study in a Murine Model.
Simmerman E; Qin X; Yu JC; Baban B
J Surg Res; 2019 Mar; 235():210-215. PubMed ID: 30691796
[TBL] [Abstract][Full Text] [Related]
25. Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials.
Yun S; Vincelette ND; Green MR; Wahner Hendrickson AE; Abraham I
Cancer Med; 2016 Jul; 5(7):1481-91. PubMed ID: 27167347
[TBL] [Abstract][Full Text] [Related]
26. The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
Suarez-Kelly LP; Kemper GM; Duggan MC; Stiff A; Noel TC; Markowitz J; Luedke EA; Yildiz VO; Yu L; Jaime-Ramirez AC; Karpa V; Zhang X; Carson WE
Oncotarget; 2016 Dec; 7(49):81172-81186. PubMed ID: 27783987
[TBL] [Abstract][Full Text] [Related]
27. CX-F9, a novel RSK2 inhibitor, suppresses cutaneous melanoma cells proliferation and metastasis through regulating autophagy.
Zhang X; Cai L; Zhao S; Long J; Li J; Wu L; Su J; Zhang J; Tao J; Zhou J; Chen X; Peng C
Biochem Pharmacol; 2019 Oct; 168():14-25. PubMed ID: 31207212
[TBL] [Abstract][Full Text] [Related]
28. 22β-hydroxytingenone induces apoptosis and suppresses invasiveness of melanoma cells by inhibiting MMP-9 activity and MAPK signaling.
Aranha ESP; Portilho AJS; Bentes de Sousa L; da Silva EL; Mesquita FP; Rocha WC; Araújo da Silva FM; Lima ES; Alves APNN; Koolen HHF; Montenegro RC; Vasconcellos MC
J Ethnopharmacol; 2021 Mar; 267():113605. PubMed ID: 33232779
[TBL] [Abstract][Full Text] [Related]
29. Piperlongumine Induces Apoptosis in Human Melanoma Cells Via Reactive Oxygen Species Mediated Mitochondria Disruption.
Song X; Gao T; Lei Q; Zhang L; Yao Y; Xiong J
Nutr Cancer; 2018 Apr; 70(3):502-511. PubMed ID: 29543494
[TBL] [Abstract][Full Text] [Related]
30. Targeting multiple key signaling pathways in melanoma using leelamine.
Gowda R; Madhunapantula SV; Kuzu OF; Sharma A; Robertson GP
Mol Cancer Ther; 2014 Jul; 13(7):1679-89. PubMed ID: 24688050
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
32. A Review of the Therapeutic Antitumor Potential of Cannabinoids.
Bogdanović V; Mrdjanović J; Borišev I
J Altern Complement Med; 2017 Nov; 23(11):831-836. PubMed ID: 28799775
[TBL] [Abstract][Full Text] [Related]
33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
34. Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo.
Cholewa BD; Ndiaye MA; Huang W; Liu X; Ahmad N
Cancer Lett; 2017 Jan; 385():179-187. PubMed ID: 27793694
[TBL] [Abstract][Full Text] [Related]
35. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
36. Review of natural compounds for potential skin cancer treatment.
Chinembiri TN; du Plessis LH; Gerber M; Hamman JH; du Plessis J
Molecules; 2014 Aug; 19(8):11679-721. PubMed ID: 25102117
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant treatment for stage III and IV cutaneous melanoma.
Gorry C; McCullagh L; O'Donnell H; Barrett S; Schmitz S; Barry M; Curtin K; Beausang E; Barry R; Coyne I
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012974. PubMed ID: 36648215
[TBL] [Abstract][Full Text] [Related]
38. Kalantuboside B induced apoptosis and cytoprotective autophagy in human melanoma A2058 cells: An in vitro and in vivo study.
Hseu YC; Cho HJ; Gowrisankar YV; Thiyagarajan V; Chen XZ; Lin KY; Huang HC; Yang HL
Free Radic Biol Med; 2019 Nov; 143():397-411. PubMed ID: 31442557
[TBL] [Abstract][Full Text] [Related]
39. O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms.
Kargl J; Haybaeck J; Stančić A; Andersen L; Marsche G; Heinemann A; Schicho R
J Mol Med (Berl); 2013 Apr; 91(4):449-58. PubMed ID: 22965195
[TBL] [Abstract][Full Text] [Related]
40. Control of the cell survival/death decision by cannabinoids.
Guzmán M; Sánchez C; Galve-Roperh I
J Mol Med (Berl); 2001; 78(11):613-25. PubMed ID: 11269508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
